GR3023312T3 - Therapeutically effective topical application of st1435. - Google Patents

Therapeutically effective topical application of st1435.

Info

Publication number
GR3023312T3
GR3023312T3 GR970400968T GR970400968T GR3023312T3 GR 3023312 T3 GR3023312 T3 GR 3023312T3 GR 970400968 T GR970400968 T GR 970400968T GR 970400968 T GR970400968 T GR 970400968T GR 3023312 T3 GR3023312 T3 GR 3023312T3
Authority
GR
Greece
Prior art keywords
therapeutically effective
topical application
effective topical
skin
blood
Prior art date
Application number
GR970400968T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Original Assignee
Robertson Dale N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robertson Dale N filed Critical Robertson Dale N
Publication of GR3023312T3 publication Critical patent/GR3023312T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
GR970400968T 1990-06-01 1997-05-02 Therapeutically effective topical application of st1435. GR3023312T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01
PCT/US1991/003697 WO1991018570A1 (en) 1990-06-01 1991-05-24 Therapeutically effective topical application of st1435

Publications (1)

Publication Number Publication Date
GR3023312T3 true GR3023312T3 (en) 1997-08-29

Family

ID=24120850

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400968T GR3023312T3 (en) 1990-06-01 1997-05-02 Therapeutically effective topical application of st1435.

Country Status (10)

Country Link
US (1) US5651973A (el)
EP (3) EP0600873B1 (el)
JP (1) JP2625254B2 (el)
AT (2) ATE151977T1 (el)
CA (1) CA2083404C (el)
DE (2) DE69133077T2 (el)
DK (2) DK0754456T3 (el)
ES (2) ES2180690T3 (el)
GR (1) GR3023312T3 (el)
WO (1) WO1991018570A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0754456T3 (da) * 1990-06-01 2002-11-11 Population Council Inc Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003235716A1 (en) * 2002-01-17 2003-07-30 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
US8602961B2 (en) * 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110220817A1 (en) * 2008-08-12 2011-09-15 Moore John W Method of reducing the distortion of the electromagnetic field
ES2641613T3 (es) 2009-12-17 2017-11-10 The Population Council, Inc. Gel transdérmico de Nestorone®/Estradiol
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
MX2017006207A (es) 2014-11-25 2017-07-31 Buckman Laboratories Int Inc Acondicionador y limpiador de fieltro.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (el) * 1969-02-13 1970-08-17
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (el) * 1987-04-02 1990-06-29 Ciba Geigy Ag
JP3238389B2 (ja) * 1988-10-27 2001-12-10 シエーリング アクチエンゲゼルシヤフト ゲストデン含有の経皮適用のための薬剤
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
DK0754456T3 (da) * 1990-06-01 2002-11-11 Population Council Inc Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
EP0600873A4 (en) 1993-09-02
ES2099747T3 (es) 1997-06-01
EP1093816A2 (en) 2001-04-25
DK0754456T3 (da) 2002-11-11
DE69133077T2 (de) 2002-11-07
EP0754456A3 (en) 2000-02-02
ES2180690T3 (es) 2003-02-16
JPH07502253A (ja) 1995-03-09
EP0754456A2 (en) 1997-01-22
CA2083404A1 (en) 1991-12-02
WO1991018570A1 (en) 1991-12-12
DK0600873T3 (da) 1997-05-20
EP1093816A3 (en) 2003-10-22
EP0754456B1 (en) 2002-07-24
DE69133077D1 (de) 2002-08-29
DE69125855D1 (de) 1997-05-28
US5651973A (en) 1997-07-29
EP0600873B1 (en) 1997-04-23
EP0600873A1 (en) 1994-06-15
JP2625254B2 (ja) 1997-07-02
DE69125855T2 (de) 1997-07-31
CA2083404C (en) 2001-02-20
ATE220912T1 (de) 2002-08-15
ATE151977T1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
GR3023312T3 (en) Therapeutically effective topical application of st1435.
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
AU549481B2 (en) Hair growing agent
PH16059A (en) Therapeutic system for administering clonidine transdermally
ATE196082T1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
EP0342055A3 (en) Treatment of skin disorders
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
AU8436401A (en) Methods and pharmaceutical compositions for healing wounds
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
CA2394471A1 (en) External preparation for treating pruritus
AU4132397A (en) Therapeutic formulations containing venom or venom anti-serum either lone or in combination for the therapeutic prophylaxis and therapy of neoplasms
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
AU603375B2 (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
ES469022A1 (es) Un procedimiento de preparacion del nuevo compuesto acido (2-isopropil-4-(2-tenoil)-5-metil)-fenoxi-acetico.
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
JPS53107478A (en) Purification of urokinase
GB2011256A (en) Aluminium compounds or therapeutic use
NO172587C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider med 19,11beta-brubinding